David M. Cordani
President and CEO
|
![]() |
|
Routing W2SLT
900 Cottage Grove Road
Bloomfield, CT 06152
Telephone 860.226.7482
Facsimile 860.226.3099
|
§ |
Base Salary – will increase to a pre-tax annualized rate of $675,000. This amount will be reviewed annually based on your performance and pay position relative to the competitive market.
|
§ |
Annual Incentive – your annual target will increase to $750,000 for the 2017 performance year. As you are aware, annual incentive is typically paid in the first quarter of the year following the performance period and is not considered earned until the date paid.
|
§ |
Long-Term Incentive – your annual long-term opportunity will become $2,100,000 and will continue to consist of the following two components:
|
- |
Stock Options – grants are typically awarded in the first quarter each year and may vary from 0 to 200% of target based on individual performance and potential. Options typically vest over a 3 year period and expire no later than 10 years after grant. The 2017 annual target is $1,050,000.
|
- |
Strategic Performance Shares (SPS) – grants are typically awarded in the first quarter of each year and may vary from 0 to 200% of target based on individual performance and potential. SPS awards are typically paid or vested three years after the beginning of the performance period. Awards are not considered earned until the date paid or vested. The 2017 annual target is $1,050,000.
|
§ |
Stock Ownership Guidelines – To align management and shareholder interests Cigna executives are subject to stock ownership guidelines. The stock ownership guideline for your position as an Executive Officer will become 3 times your new base salary.
|
§ |
a transitional SPS award with a grant date value $568,750; shares earned (paid) in 2020 per the plan's formula
|